Table 4.
Step 1 | Step 2 | |||||||
---|---|---|---|---|---|---|---|---|
β | SE | Wald | 95% CI | β | SE | Wald | 95% CI | |
Age | .05 | .03 | 1.96 | .98–1.12 | .05 | .03 | 2.04 | .98–1.12 |
Education | −.03 | .03 | .75 | .91–1.04 | −.02 | .03 | .43 | .91–1.05 |
ADLs | .50 | .18 | 7.85* | 1.16–2.36 | .49 | .18 | 7.22* | 1.14–2.32 |
IADLs | .45 | .32 | 1.95 | .83–2.93 | .43 | .32 | 1.82 | .82–2.85 |
Arthritis | .38 | .22 | 2.99 | .95–2.25 | .33 | .22 | 2.20 | .90–2.16 |
Pulmonary | −.74 | .55 | 1.76 | .16–1.42 | −.56 | .56 | 1.03 | .19–1.70 |
Cancer | .23 | .29 | .63 | .71–2.23 | .18 | .30 | .38 | .67–2.15 |
S-R Health Δ | .69 | .17 | 15.89*** | 1.42–2.81 | .65 | .18 | 13.41*** | 1.35–2.70 |
Vasc Dep D1 | .43 | .23 | 3.48+ | .98–2.40 | ||||
Vasc Dep D2 | 1.04 | .37 | 8.07** | 1.38–5.84 | ||||
Constant | −7.08 | 2.99 | 5.62 | −7.35 | 3.01 | 5.95 |
p≤.05;
p≤.01;
p≤.001;
p=.06
S-R Hlth Δ=Self-rated health change; ADLs=Activities of Daily Living; IADLs=Instrumental Activities of Daily Living; Vasc Dep D1: Respondents with either high CVB or CES-D scores≥3; Vasc Dep D2: Respondents with high CVB or CES-D scores≥3 scored 1, respondents with both high CVB and CES-D scores≥3 scored 2.